Skip to main content

Arcturus Therapeutics Holdings Inc.

ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768224

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Arcturus Therapeutics Holdings Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
+12 vs. Q1 2026
Shares held
25.0M
+702.0K (+2.9%) vs. Q1 2026
Total value
$167.9M
−$19.4M (−10.3%) vs. Q1 2026
New holders
20
56 more added
Sold out
8
40 more reduced

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 135 institutions
Q1 2021: 162 institutionsQ2 2021: 139 institutionsQ3 2021: 157 institutionsQ4 2021: 139 institutionsQ1 2022: 129 institutionsQ2 2022: 128 institutionsQ3 2022: 117 institutionsQ4 2022: 113 institutionsQ1 2023: 124 institutionsQ2 2023: 144 institutionsQ3 2023: 147 institutionsQ4 2023: 166 institutionsQ1 2024: 179 institutionsQ2 2024: 171 institutionsQ3 2024: 164 institutionsQ4 2024: 149 institutionsQ1 2025: 147 institutionsQ2 2025: 145 institutionsQ3 2025: 137 institutionsQ4 2025: 121 institutionsQ1 2026: 124 institutionsQ2 2026: 135 institutions
Value heldQ2 2026: $167.9M
Q1 2021: $776.0MQ2 2021: $694.0MQ3 2021: $909.0MQ4 2021: $736.2MQ1 2022: $578.1MQ2 2022: $353.6MQ3 2022: $328.1MQ4 2022: $383.9MQ1 2023: $557.9MQ2 2023: $677.6MQ3 2023: $643.1MQ4 2023: $801.6MQ1 2024: $918.7MQ2 2024: $640.0MQ3 2024: $609.3MQ4 2024: $452.5MQ1 2025: $282.9MQ2 2025: $336.3MQ3 2025: $476.8MQ4 2025: $145.1MQ1 2026: $187.3MQ2 2026: $167.9M
Institutions holding ARCT and their total value by quarter
QuarterHoldersValue
Q2 2026135$167.9M
Q1 2026124$187.3M
Q4 2025121$145.1M
Q3 2025137$476.8M
Q2 2025145$336.3M
Q1 2025147$282.9M
Q4 2024149$452.5M
Q3 2024164$609.3M
Q2 2024171$640.0M
Q1 2024179$918.7M
Q4 2023166$801.6M
Q3 2023147$643.1M
Q2 2023144$677.6M
Q1 2023124$557.9M
Q4 2022113$383.9M
Q3 2022117$328.1M
Q2 2022128$353.6M
Q1 2022129$578.1M
Q4 2021139$736.2M
Q3 2021157$909.0M
Q2 2021139$694.0M
Q1 2021162$776.0M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Arcturus Therapeutics Holdings Inc.; share changes are against Q1 2026.

Institutions holding ARCT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Russell Investments Group, Ltd.75,903$510.1K0.00%+44,199+139.4%Added
Marshall Wace, LLP77,269$519.2K0.00%+77,269New
Bank of New York Mellon Corp80,314$539.7K0.00%+5,317+7.1%Added
Quantinno Capital Management LP85,875$577.1K0.00%+14,522+20.4%Added
Morgan Stanley97,406$654.6K0.00%−28,729−22.8%Reduced
Invesco Ltd.104,188$700.1K0.00%−9,382−8.3%Reduced
Davy Global Fund Management Ltd126,390$849.3K0.05%+12,135+10.6%Added
Acadian Asset Management LLC131,451$880.0K0.00%−149,049−53.1%Reduced
Jump Financial, LLC138,209$928.8K0.01%+69,916+102.4%Added
Vanguard Fiduciary Trust Co174,048$1.17M0.00%+4,236+2.5%Added
JPMorgan Chase & Co195,704$1.33M0.00%−2,111−1.1%Reduced
Northern Trust Corp204,578$1.37M0.00%−15,035−6.8%Reduced
Heartland Advisors Inc219,300$1.47M0.07%−36,700−14.3%Reduced
Dimensional Fund Advisors LP221,322$1.49M0.00%−67,033−23.2%Reduced
Point72 Asset Management, L.P.231,582$1.56M0.00%+167,737+262.7%Added
Charles Schwab Investment Management Inc231,628$1.56M0.00%+15,128+7.0%Added
BNP Paribas Arbitrage, SA261,789$1.76M0.00%+66,929+34.3%Added
Goldman Sachs Group Inc309,863$2.08M0.00%+111,182+56.0%Added
Millennium Management LLC336,996$2.26M0.00%−141,561−29.6%Reduced
Hennion & Walsh Asset Management, Inc.346,207$2.33M0.07%+66,528+23.8%Added
Empire Life Investments Inc.366,217$2.46M0.14%−17,276−4.5%Reduced
D. E. Shaw & Co., Inc.392,358$2.64M0.00%+140,324+55.7%Added
UBS Group AG490,632$3.30M0.00%+32,355+7.1%Added
State Street Corp569,598$3.83M0.00%+25,735+4.7%Added
Jacobs Levy Equity Management, Inc647,511$4.35M0.02%+448,783+225.8%Added
AQR Capital Management LLC675,014$4.54M0.00%+513,736+318.5%Added
Geode Capital Management, LLC693,660$4.66M0.00%+32,732+5.0%Added
Vanguard Portfolio Management LLC951,575$6.39M0.00%−26,347−2.7%Reduced
Two Sigma Investments, LP1,091,137$7.33M0.01%+9,353+0.9%Added
Vanguard Capital Management LLC1,114,956$7.49M0.00%+7,936+0.7%Added
Nikko Asset Management Americas, Inc.1,960,458$13.1M0.17%−328,477−14.4%Reduced
Sumitomo Mitsui Trust Holdings, Inc.1,963,123$13.2M0.01%−325,812−14.2%Reduced
BlackRock, Inc.2,614,012$17.6M0.00%+7310.0%Added
ARK Investment Management LLCSuperinvestorARK Invest2,901,635$19.5M0.13%+132,117+4.8%Added
Federated Hermes, Inc.3,303,640$22.2M0.03%00.0%Unchanged
Odyssean, LLC0$00.00%−22,956−100.0%Sold out
SG Americas Securities, LLC0$00.00%−20,972−100.0%Sold out
Castleview Partners, LLC0$00.00%−16,857−100.0%Sold out
HRT Financial LP0$00.00%−15,129−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−15,000−100.0%Sold out
MAI Capital Management0$00.00%−465−100.0%Sold out
Wealth Preservation Advisors, LLC0$00.00%−40−100.0%Sold out
Root Financial Partners, LLC0$00.00%−22−100.0%Sold out
CWM, LLC––––Not filed